|Bid||0.0850 x 0|
|Ask||0.0850 x 0|
|Day's Range||0.0850 - 0.0900|
|52 Week Range||0.0700 - 0.1750|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 16, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MONTREAL, Nov. 5, 2020 /CNW Telbec/ - Cannara Biotech Inc.
MONTREAL , July 7, 2020 /CNW/ - Cannara Biotech Inc. ("Cannara") (LOVE.CN) (LOVFF) (8CB.F) announced today it has closed on its previously announced offer to acquire all of the issued and outstanding shares of Global shopCBD.com Inc. ("Global") not already owned by Cannara (the "Transaction"). Pursuant to the terms of a share exchange agreement dated May 26, 2020 among Cannara, Global and the shareholders of Global, Cannara has acquired 99.8% of the issued and outstanding shares of Global that it did not already own in consideration for the issuance of 23,145,110 common shares of Cannara pro rata to the shareholders of Global at a deemed price of $0.10 per share (the "Payment Shares"). The Payment Shares are not subject to any hold periods under applicable securities laws.
MONTREAL , July 6, 2020 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (LOVE.CN) (LOVFF) (8CB.F) announced today it has finalized a non-binding Letter of Intent (LOI) with the Société québécoise du cannabis (the "SQDC"). With this LOI, Cannara will dedicate its entire first year production of premium quality cannabis to its home market of Québec. The Company also announced the hiring of its 100th employee at its facility in Farnham , Québec with more hiring forthcoming.